Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
STRONG BUY =(DCTH will go over $2.00 by November 2017. Not needed R/S which was rejected 2 month a go by 78% shareholders.
Do you think they did not read management notice regarding desisting from Nasdaq =steal after revue all the materials they belie that (DCTH) will be worth mach more.
Do you all belie the 78% registered shareholders stooped ?
NO R/S -no BC- NO Desisting when over 100 million share traded a day = Only solution find the Partner to finish the revue and enjoy fruits of the fame which company will save millions lives.
I relay belie to the DCTH medication which curing censer . This not investment it is duty all humanity to help to the DCTH.
PLEASE READ CORRECTLY -
On August 15, 2017 DCTH received written notification from the Listing Qualifications Staff of The NASDAQ
REPLY BY DCTH =The Company intends to timely request a hearing before the Panel, which request will stay any suspension or desisting action by Nasdaq at least until the hearing process concludes and any extension granted by the Panel expires.
SO DCTH TIMELY REQUESTED HEARING
On August 15, 2017, Delcath Systems, Inc, Inc. (the “Company”) received written notification from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s continued non-compliance with the minimum stockholder’s equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Rule”), the Staff had determined to delist the Company’s securities from Nasdaq (the “Staff Determination”) unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”).
The Company intends to timely request a hearing before the Panel, which request will stay any suspension or delisting action by Nasdaq at least until the hearing process concludes and any extension granted by the Panel expires. At the hearing, the Company will present its plan to evidence compliance with the Rule, and request an extension of time within which to do so.
Stop speculations .(DCTH) will get voucher from FDA before November which worth billions = This is facts no one can not deny.
(DCTH will go over $2.00 by November 2017. Not needed R/S which was rejected 2 month a go by 78% shareholders.
Do you think they did not read management notice regarding desisting from Nasdaq =steal after revue all the materials they belie that (DCTH) will be worth mach more. 78% shareholders not stooped .
APPEAL WAS FILED
ITEM 3.01 Notification of Failure to Satisfy a Continued Listing Rule or Standard
On August 15, 2017, Delcath Systems, Inc, Inc. (the “Company”) received written notification from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s continued non-compliance with the minimum stockholder’s equity requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(2) (the “Rule”), the Staff had determined to delist the Company’s securities from Nasdaq (the “Staff Determination”) unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”).
The Company intends to timely request a hearing before the Panel, which request will stay any suspension or delisting action by Nasdaq at least until the hearing process concludes and any extension granted by the Panel expires. At the hearing, the Company will present its plan to evidence compliance with the Rule, and request an extension of time within which to do so.
As previously disclosed by the Company, on February 13, 2017, Staff notified the Company that the bid price of its listed security had closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, did not comply with Listing Rule 5550(a)(2) (the “Rule”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until August 14, 2017 to regain compliance. The Company did not evidence compliance with the Rule by August 14, 2017, and was not eligible for an additional 180 day extension because it does not meet the stockholder’s equity requirement, which resulted in the issuance of the Staff Determination.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DELCATH SYSTEMS, INC.
Date: August 21, 2017 By: /s/ Jennifer Simpson
Name: Jennifer Simpson
Title: President and Chief Executive Officer
. https://ih.advfn.com/p.php?pid=nmona&article=75489238
Buy Alert-The Company intends to timely request a hearing to stay at Nasdaq until the hearing process concludes. https://ih.advfn.com/p.php?pid=nmona&article=75489238
Shareholders General yearly meeting new management able request in writing prier 60 days notice.
R/S management request only ones a Year not every month after it was rejected by 78% shareholders on the record it is a Law
US PATENT # US 9,707,331B2 Date of failing for the Patent July 18,2017 Buy out offer on the table any moment we will get information /
DCTH recived New patent US PATENT # US 9,707,331B2 Date of Patent July 18,2017
$DCTH for Noobies we are waiting on ICC TRIAL APPROVAL we just got a patent approved ICC trial is a DEVICE Bullish
R/S proposal rejected till next shareholders meeting by year 2018
http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
Positive thinking will help you to slip over to bed. Tomorrow we all see what the investors will do . Lots scared to loose money -others have a fun. You chose by yourself what to do when the time cams. win sum lose sum . It is your decision Right! Good luck to all = Good Night . Sorry I do not see well making typos.
Pre-Market starting price $0.86 closing $1.29 due buyout proposal BUY-BUY as match you able.
NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
It is free country think and do as you please =But by law impossible ask your broker .
This pops bed losers NOT SHORTS Remember all!
-NO institutions investors allowed to cover penny shorts shares by law like banks, hags fond, any fond, insurgence =Only allowed to cover 30% stock worth over $1.50 or $2.50 a share .
NO SHORTS IN PENNY SHARES !
Pre-Market starting price $0.86 closing $1.29 due buyout proposal BUY-BUY-BUY as match you able.
NO R/S http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
Pre-Market starting price $0.86 closing $1.29 due buyout proposal BUY-BUY-BUY as match you able.
! NO R/S http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) look at this side
Date : 07/12/2017 @ 4:34PM
Source : Edgar (US Regulatory)
Stock : Delcath Systems, Inc. (MM) (DCTH)
Quote : 0.139 0.0 (0.00%) @ 4:00AM
UNDER -STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING
In order for a stockholder proposal to be eligible for inclusion in our proxy statement for the 2018 annual meeting of stockholders, the proposal must be received by the Corporate Secretary not later than January 9, 2018, and must otherwise comply with the requirements of Rule 14a-8(e) of the Securities Exchange Act of 1934. In addition, in order for a stockholder to present a proposal or other matter or to nominate a person for election as a director at the 2018 annual meeting of stockholders, the stockholder must give Delcath written notice of the proposal or other matter to be presented at the meeting no later than January 9, 2018, and must otherwise comply with our amended and restated certificate of incorporation. If the date set for the 2018 annual meeting is more than 30 calendar days before or after June 5, 2018, such notice must instead be received no later than 60 calendar days before the date set for such meeting. Proposals or notices of intent to present a proposal should be addressed to the Corporate Secretary, Delcath Systems, Inc., 1633 Broadway, Suite 22C, New York, New York 10019, and should be sent by overnight delivery or certified mail, return receipt requested. If a stockholder fails to provide timely notice of a proposal to be presented at the 2018 annual meeting, the proxies designated by the Board will have discretionary authority to vote on the proposals.
/s/ Jennifer K. Simpson
New York, New York Jennifer K. Simpson, Ph.D.
[?], 2017 President, Director and Executive Officer
18
STRONG BUY ! NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
STRONG BUY ! NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) look at this side
Date : 07/12/2017 @ 4:34PM
Source : Edgar (US Regulatory)
Stock : Delcath Systems, Inc. (MM) (DCTH)
Quote : 0.139 0.0 (0.00%) @ 4:00AM
UNDER -STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING
In order for a stockholder proposal to be eligible for inclusion in our proxy statement for the 2018 annual meeting of stockholders, the proposal must be received by the Corporate Secretary not later than January 9, 2018, and must otherwise comply with the requirements of Rule 14a-8(e) of the Securities Exchange Act of 1934. In addition, in order for a stockholder to present a proposal or other matter or to nominate a person for election as a director at the 2018 annual meeting of stockholders, the stockholder must give Delcath written notice of the proposal or other matter to be presented at the meeting no later than January 9, 2018, and must otherwise comply with our amended and restated certificate of incorporation. If the date set for the 2018 annual meeting is more than 30 calendar days before or after June 5, 2018, such notice must instead be received no later than 60 calendar days before the date set for such meeting. Proposals or notices of intent to present a proposal should be addressed to the Corporate Secretary, Delcath Systems, Inc., 1633 Broadway, Suite 22C, New York, New York 10019, and should be sent by overnight delivery or certified mail, return receipt requested. If a stockholder fails to provide timely notice of a proposal to be presented at the 2018 annual meeting, the proxies designated by the Board will have discretionary authority to vote on the proposals.
/s/ Jennifer K. Simpson
New York, New York Jennifer K. Simpson, Ph.D.
[?], 2017 President, Director and Executive Officer
18
STRONG BUY ! NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
STRONG BUY ! NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 http://phx.corporate-ir.net/phoenix.zhtml?c=123840&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExNjk1MTA2JkRTRVE9MSZTRVE9MjEmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3d%3d
STRONG BUY ! NO R/S = STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING -page 17 explanation and warning regarding R/Sat meeting year 2018 =because the R/S was rejected in 2017 by majority shareholders /
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) look at this side
Date : 07/12/2017 @ 4:34PM
Source : Edgar (US Regulatory)
Stock : Delcath Systems, Inc. (MM) (DCTH)
Quote : 0.139 0.0 (0.00%) @ 4:00AM
UNDER -STOCKHOLDER PROPOSALS FOR THE 2018 ANNUAL MEETING
In order for a stockholder proposal to be eligible for inclusion in our proxy statement for the 2018 annual meeting of stockholders, the proposal must be received by the Corporate Secretary not later than January 9, 2018, and must otherwise comply with the requirements of Rule 14a-8(e) of the Securities Exchange Act of 1934. In addition, in order for a stockholder to present a proposal or other matter or to nominate a person for election as a director at the 2018 annual meeting of stockholders, the stockholder must give Delcath written notice of the proposal or other matter to be presented at the meeting no later than January 9, 2018, and must otherwise comply with our amended and restated certificate of incorporation. If the date set for the 2018 annual meeting is more than 30 calendar days before or after June 5, 2018, such notice must instead be received no later than 60 calendar days before the date set for such meeting. Proposals or notices of intent to present a proposal should be addressed to the Corporate Secretary, Delcath Systems, Inc., 1633 Broadway, Suite 22C, New York, New York 10019, and should be sent by overnight delivery or certified mail, return receipt requested. If a stockholder fails to provide timely notice of a proposal to be presented at the 2018 annual meeting, the proxies designated by the Board will have discretionary authority to vote on the proposals.
/s/ Jennifer K. Simpson
New York, New York Jennifer K. Simpson, Ph.D.
[?], 2017 President, Director and Executive Officer
18
http://ih.advfn.com/p.php?pid=nmona&article=75225988#D397812DPRE14A_HTM_ROM397812_4
STRONG BUY NO R/S proposal till 2018
https://ih.advfn.com/p.php?pid=nmona&article=75478160
BUY ALERT- Be smart you can see that fact that , somebody bought a 268 million shares . Do you belie they are stooped . One selling 600000 block shares but other buying millions . They all believe the shares price will incise 400% in price Monday /
I agree with you 100% , I just call to the fact re appeal, it was send a week a go Today after 4-30 pm or Monday morning it will be officially filed . (DCTH) will fly at Monday pre-market Have a good weekend /
NO R/S 73% shareholders rejected revers split -New Patent coming soon -In Frankfurt closed at $0.231 a share
TIME TO BUY-all indicator pointing out closing at $0.26.5
STRONG BUY ALERT! ($1.20 today at closing ) Ermanno Santilli, Chief Executive Officer of MagneGas, stated, "We experienced a 50.1% increase in metal cutting fuel revenue in the second quarter of 2017 versus the same period last year.
As an example of our success, our Sarasota, Florida location, opened in January of this year, is on pace to generate over $1 million in annualized revenue within the coming quarters.
As a result, we see a clear path to profitability through continued organic growth, accretive acquisitions, reduction in our production costs, and careful management of our expenses," added Mr. Santilli.
"Through the introduction of butanol as a feedstock and further procedural and equipment improvements, our production rates have increased over 150% with a 50% reduction in production costs.
"In June, we were awarded a grant from the United States Department of Agriculture (USDA) to accelerate commercialization of the Company's plasma arc Venturi® sterilization system for the treatment of pathogens and nutrients found in animal biosolid wastes.
We are now advancing a number of additional sterilization projects we have been developing in the U.S., Europe, Latin America and Asia.
"In July, we were awarded an important patent by the US Patent and Trademark Office related to use of our technology to increase the energy density of fuels or as an additive to current fuels.
We also announced that we have filed a provisional patent application on our next-generation gasification system. The provisional patent application entails the use of a plasma arc in conjunction with certain fluids and powdered materials such as coal, plastics, and potentially the Company's primary feedstock, butanol.
http://ih.advfn.com/p.php?pid=nmona&article=75477505
SELL- SELL-SELL=I AM FILING TO START INVESTIGATION DCTH BOARD
Investors Alert on Capricor Therapeutics, Inc. (CAPR)
By Mack Mortenson -18th August 2017
https://www.wallstreetmorning.com/2017/08/18/investors-alert-on-capricor-therapeutics-inc-capr/
YES it going to get desisted
TIME TO SELL=SELL-SELL
Pareteum Awarded 2-Year Contract for its Global Mobility Cloud Services from Europe-Based Value-Added Service Customer ACCESSWIRE August 3, 2017
https://finance.yahoo.com/news/pareteum-awarded-2-contract-global-123000199.html
Maxim Group Reports Initiation of Interpace Diagnostics Gr (IDXG) with $5
STRONG BUY-All indicators pointing out we will reach $1.20 today and tomorrow
SELL ALERT- No Volume only 211293 something wrong . Any thoughts?
R/S Alert! Assuming the Company is able to effect a reverse stock split as proposed in its recent consent solicitation statement filed with the SEC on July 26, 2017, management believes that its capital resources are adequate to fund operating activities through the end of 2017 Read at 10Q
August 8, 2017
STRONG BUY =(CAPR share price to rise to $21.50 =According to Financial Times, The one analyst offering a 12 month price target expects Capricor Therapeutics Inc share price to rise to 21.50 in the next year from the last price of 1.06.
Influential Analyst Rating Changes: Charter Communications, Inc. (CHTR), Capricor Therapeutics, Inc. (CAPR)
August 1, 2017 Loren Roberson
http://thewellesleysnews.com/2017/08/01/influential-analyst-rating-changes-charter-communications-inc-chtr-capricor-therapeutics-inc-capr/
NEWS =$$$$$$-Revenues for telecom operators from IoT and M2M are on track to reach $1 billion on an annual basis in the next few years and Pareteum is positioned to aggressively capture a growing portion of this market."
https://finance.yahoo.com/news/pareteum-announces-live-implementation-global-123800109.html
It has been filed in SEC.